BBC ETF (Virtus LifeSci Biotech Clinical Trials ETF) is managed by Virtus Investment Partners with $55.8M in net assets. BBC expense ratio is 0.65%, holding 123 positions across sectors including Health Care, Unknown, Industrials. Inception date: 2014-12-16.

BBC performance shows a YTD return of 31.98%. The 1-year return is 177.76% and the 5-year return is 1.68%. BBC dividend yield stands at 1.24%, paid annually.

BBC top holdings include Erasca Inc (2.1%), Tango Therapeutics Inc. (1.8%), Enliven Therapeutics Inc (1.8%), Spyre Therapeutics Inc (1.6%), Oruka Therapeutics Inc Orka (1.6%). View all BBC holdings, sector breakdown, or dividend history.

BBC can be compared against other funds using the overlap calculator or side-by-side comparison tool. BBC alternatives are available via the screener, along with tax-loss harvesting opportunities.